BioNTech/Pfizer's new vaccine has high immune response against Omicron 26/06/2022 (VOVWORLD) - Pfizer and BioNTech on Saturday announced positive data evaluating the safety, tolerability, and immunogenicity of their two Omicron-adapted COVID-19 vaccine candidates